info@sandexis.co.uk


Home

Team

News

Sandexis logo
2016
January 2016
Sandexis complete their 50th due diligence, third party review

January 2016
Sandexis / DNDi publish neglected tropical disease (NTD) open-access manuscript in J. Med. Chem. of their hit-to-lead work with DNDi resulting in a novel class of antileishmanial compounds with activity in vitro and in vivo.

2015
December 2015
Sandexis are delighted to announce their collaboration with the University of Sheffield for the discovery of ADM2 antagonists has received funding from the Wellcome Trust Seeding Drug Discovery initiative

November 2015
Gavin visits Japan as part of the DNDi / GHIT collaboration

November 2015
Karl attending the 1st RSC / SCI symposium on Fibrosis in UK

October 2015
Sandexis celebrates 4 year anniversary

May 2015
Sandexis publish a review of Small-molecule anti-inflammatory asthma patents for the years 2013-2014.


April 2015
Sandexis supply medicinal chemistry services to Calchan Ltd. Karl will be consultant Director of Medicinal Chemistry for the London based biotech.


February 2015
Karl and James are lecturing the MSc Drug Design course at University of Kent, Canterbury


2014
October 2014
Sandexis celebrates 3 year anniversary

September 2014
Sandexis move to new, larger premises in Innovation
House, Discovery Park in Sandwich, Kent

July 2014
Sandexis complete their 30th due diligence, 3rd party review.

May 2014
Karl is attending Kinase 2014: past, present and beyond. 6th RSC / SCI symposium on kinase inhibitor design, Cambridge UK

April 2014
Paul is attending the 25th Symposium on Medicinal Chemistry in Eastern England, Hatfield UK

February 2014
Karl and James are lecturing the MSc Drug Design course at University of Kent, Canterbury


2013
December 2013
RSC Publishes Book Pain Therapeutics: Current and Future Treatment Paradigms featuring ion channel modulator chapter edited by Karl

October 2013
Sandexis celebrates 2 year anniversary

September
2013
Gavin attends RSC-SCI Medicinal Chemistry Symposium, Cambridge UK

April 2013
Paul Glossop joins Sandexis

March 2013
Joint J Med Chem publication with Cyclofluidic
on design of novel Abl kinase inhibitors

February 2013
Sandexis move to new premises in Innovation
House, Discovery Park in Sandwich, Kent



LinkedIn
 Sandexis Medicinal Chemistry Ltd 2015
Company No. 07767700
Postal address: Innovation House, Discovery Park, Ramsgate Road, Sandwich, Kent, CT13 9ND, UK
Business registered address: 45 Queen Street, Deal, Kent, CT14 6EY, UK